Non-interventional study to assess the safety profile of idelalisib in patients with refractory follicular lymphoma (FL)

27/06/2017
02/07/2024
EU PAS number:
EUPAS19618
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

GS-EU-313-4172 Protocol Final V1.1 13Jun2017

English (679.41 KB - PDF) View document
Updated protocol

GS-EU-313-4172-16.1.1-appendix-protocol Amendment 4.1_f-redact

First published: 22/02/2024
English (6.55 MB - PDF) View document
Study results
Study results

GS-EU-313-4172_Final Report Abstract_v2.0_01September2022_Approved_f-redact

English (832.36 KB - PDF) View document
Study report
Other information